This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Under $10 Poised to Pop

Supernus Pharmaceuticals

Another under-$10 stock that's trending within range of triggering a near-term breakout trade is Supernus Pharmaceuticals (SUPN - Get Report), which is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system, or CNS, diseases. This stock has been destroyed by the sellers during the last six months, with shares off by 39%.

If you take a look at the chart for Supernus Pharmaceuticals, you'll notice that this stock has been trending range-bound for the last two months, after gapping down from $11 a share in early December. That range-bound action has shares of SUPN moving between $6.75 on the downside and just below $8 a share on the upside. This stock has also started to trend higher off that low of $6.75 a share and it's quickly moving within range of breaking out above the upper end of its recent sideways trading pattern.

>>4 Breakout Buys for January -- and One Sell

Market players should now look for long-biased trades in SUPN if it manages to break out above some near-term overhead resistance level $7.79 to $8 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action 242,700 shares. If that breakout hits soon, then SUPN will set up to re-fill some of that previous gap down zone that started around $11 a share.

Traders can look to buy SUPN off any weakness to anticipate that breakout and then simply use a stop that sits close to some near-term support levels at $7 to $6.93 a share. One can also buy off strength once SUPN takes out those breakout levels with volume and then simply use a stop that sits just below $7.50 a share. I would add to either position once SUPN takes out its 50-day moving average of $8.55 a share with heavy volume.
3 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
ACLS $2.87 -1.71%
DARA $0.80 0.00%
GEVO $2.72 -2.86%
RBCN $1.83 -1.61%
SUPN $21.26 0.76%

Markets

Chart of I:DJI
DOW 17,550.69 -47.51 -0.27%
S&P 500 2,093.32 -4.72 -0.22%
NASDAQ 5,105.5460 -9.8360 -0.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs